Christopher T. Veldkamp, Ph.D.
Affiliations: | 2006 | Medical College of Wisconsin, Milwaukee, WI, United States |
Area:
Biochemistry, Molecular BiologyGoogle:
"Christopher Veldkamp"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Brian F. Volkman | grad student | 2006 | Medical College of Wisconsin | |
| (Structural studies of the stromal cell-derived factor-1/CXCL12 monomer -dimer equilibrium by multidimensional NMR and fluorescence spectroscopy.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Xu T, Schou AS, Lackman JJ, et al. (2024) Chemokine Receptor N-Terminus Charge Dictates Reliance on Post-Translational Modifications for Effective Ligand Capture and Following Boosting by Defense Peptides. International Journal of Molecular Sciences. 25 |
| Witt RN, Nickel KS, Binns JR, et al. (2023) NMR indicates the N-termini of PSGL1 and CCR7 bind competitively to the chemokine CCL21. Biochemistry and Biophysics Reports. 35: 101524 |
| Brandum EP, Jørgensen AS, Calvo MB, et al. (2022) Selective Boosting of CCR7-Acting Chemokines; Short Peptides Boost Chemokines with Short Basic Tails, Longer Peptides Boost Chemokines with Long Basic Tails. International Journal of Molecular Sciences. 23 |
| Lewandowski EM, Kroeck KG, Jacobs LMC, et al. (2022) Structural Insights into Molecular Recognition by Human Chemokine CCL19. Biochemistry |
| Jørgensen AS, Brandum EP, Mikkelsen JM, et al. (2021) The C-terminal peptide of CCL21 drastically augments CCL21 activity through the dendritic cell lymph node homing receptor CCR7 by interaction with the receptor N-terminus. Cellular and Molecular Life Sciences : Cmls |
| Gutjahr JC, Crawford KS, Jensen DR, et al. (2021) The dimeric form of CXCL12 binds to atypical chemokine receptor 1. Science Signaling. 14 |
| Jørgensen AS, Larsen O, Uetz-von Allmen E, et al. (2019) Biased Signaling of CCL21 and CCL19 Does Not Rely on N-Terminal Differences, but Markedly on the Chemokine Core Domains and Extracellular Loop 2 of CCR7. Frontiers in Immunology. 10: 2156 |
| Jørgensen AS, Adogamhe PE, Laufer JM, et al. (2018) CCL19 with CCL21-tail displays enhanced glycosaminoglycan binding with retained chemotactic potency in dendritic cells. Journal of Leukocyte Biology |
| Moussouras NA, Getschman AE, Lackner ER, et al. (2017) Differences in Sulfotyrosine Binding amongst CXCR1 and CXCR2 Chemokine Ligands. International Journal of Molecular Sciences. 18 |
| Phillips AJ, Taleski D, Koplinski CA, et al. (2017) CCR7 Sulfotyrosine Enhances CCL21 Binding. International Journal of Molecular Sciences. 18 |